GlassScriptPhysician profile
Stacy M Eaton
NPI 1699132605
$883.88
in general payments reported to CMS, 2019-2025
15 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $183 · 2023: $38.91 · 2024: $234 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $228.60 | 2022-2024 | Belbuca |
| Supernus Pharmaceuticals, INC. | $144.47 | 2021 | |
| Abbvie INC. | $86.72 | 2022-2025 | |
| Grt US Holding, INC. | $83.55 | 2022 | |
| Averitas Pharma INC. | $71.36 | 2023-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $63.13 | 2025 | |
| Ironshore Pharmaceuticals INC. | $41.70 | 2024 | |
| Nevro Corp. | $29.24 | 2021 | |
| Boston Scientific Corporation | $26.26 | 2025 | General - Pain Management |
| Scilex Pharmaceuticals INC. | $23.27 | 2022 | |
| Novo Nordisk INC | $18.84 | 2024 | Ozempic, Rybelsus |
| Medline Industries LP | $17.95 | 2024 | Medline Industries, INC. |
| Medtronic, INC. | $17.83 | 2021 | |
| Ibsa Pharma INC. | $16.02 | 2025 | Flector, Licart, Tirosint |
| Valinor Pharma, LLC | $14.94 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Eaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.